// App-Quantinova.ai

11045 : Epithelial-to-mesenchymal (EMT) markers and nanomechanical signatures of circulating tumor cells (CTC) for prediction of men with castrate-sensitive versus castration-resistant prostate cancer (PCa).

Researchers

Presenter

  • Devalingam Mahalingam

Principal Investigators

  • Chun-Liang Chen

  • Tim Huang

  • Pawel A. Osmulski

  • Maria E Gaczynska

  • Ian Murchie Thompson

Medical Centers

  • University of Texas Health Science Center San Antonio, San Antonio, TX

  • Cancer Therapy and Research Center, The University of Texas Health Science Center at San Antonio, San Antonio, TXCancer Therapy and Research Center,University of Texas Health Science Center at San Antonio, San Antonio, TXCancer Therapy and Research Center, University of Texas Health Science Center at San Antonio, San Antonio, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • Circulating tumor cells

  • Solute Carrier Family 22 Member 3

Drug/Treatment

  • N/A

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved